Abstract
We used RNAase protection and restriction fragment length polymorphism assays to detect activating mutations of c-src in a spectrum of human tumours. No mutations were detected at codons 98, 381, 444, and 530. We conclude that mutational activation is not the mechanism of enhancement of ppWc-src specific kinase activity found in a number of human cancer types. © 1991 Macmillan Press Ltd.
Cite
CITATION STYLE
Wang, P., Fromowitz, F., Koslow, M., Hagag, N., Johnson, B., & Viola, M. (1991). C-src structure in human cancers with elevated pp60c-src activity1. British Journal of Cancer, 64(3), 531–533. https://doi.org/10.1038/bjc.1991.344
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.